جست‌وجوی استاد و پژوهشگر

• Frontotemporal dementia (FTD)
• Amyotrophic lateral sclerosis (ALS)
• Alzheimer's disease (AD)
• +۷ مورد دیگر

Sandra Cristina Vicente Almeida is an Assistant Professor in the Department of Neurology at UMass Chan Medical School, with additional appointments in the T.H. Chan School of Medicine, NeuroNexus Institute, and Morningside Graduate School of Biomedical Sciences (Departments of Interdisciplinary Graduate Program, Neuroscience, and Translational Science). Education: BS in Biochemistry from University of Coimbra, Coimbra, Portugal PhD in Cell Biology from University of Coimbra, Coimbra, Portugal Dr. Almeida's primary research focuses on elucidating the molecular mechanisms of frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), and Alzheimer's disease (AD). Her laboratory employs patient-derived induced pluripotent stem cell (iPSC) lines to generate disease-relevant neuronal cells. She has developed iPSC lines from FTD and ALS/FTD patients carrying mutations in progranulin, C9ORF72, TDP-43, and MAPT, as well as healthy controls. These iPSCs are differentiated into post-mitotic cortical and motor neurons to uncover underlying molecular and cellular defects. Her work also involves gene editing approaches to create CHMP2B mutant iPSCs for studying AD cellular pathogenesis. Analysis of Dr. Almeida's publication record from 2012 to 2024 reveals a strong focus on C9ORF72-related mechanisms in ALS/FTD, with particular emphasis on dipeptide repeat proteins, RNA toxicity, and cellular models using iPSC technology. Her research spans molecular biology, cellular neuroscience, and translational approaches to neurodegenerative diseases, with a consistent emphasis on understanding pathogenic mechanisms and identifying potential therapeutic interventions. The most cited works focus on poly(GR) toxicity, mitochondrial dysfunction, and nucleocytoplasmic transport defects in ALS/FTD. Dr. Almeida collaborates extensively with Dr. Fen-Biao Gao and other researchers in the field, as evidenced by her numerous co-authored publications. While specific grant information isn't detailed in the provided text, her extensive publication record in high-impact journals suggests significant research funding support. Her laboratory appears to focus on cellular models of neurodegeneration, particularly using iPSC technology to study patient-specific mechanisms of disease. The research emphasizes both basic molecular mechanisms and potential therapeutic approaches for ALS, FTD, and related neurodegenerative disorders.

Priscilla A. Furthمشاهده پروفایل

استاد

• Bioinformatics
• Breast Cancer
• Estrogen Signaling
• +۴ مورد دیگر

Priscilla A. Furth is a Professor at Georgetown University's Department of Oncology and Medicine, with a distinguished career in disease pathophysiology and cancer research. She serves as an Anna Boyksen Fellow at the Technical University of Munich Institute for Advanced Study (TUM-IAS) since 2023, focusing on experimental bioinformatics and gender diversity in science. M.D. from Yale University (1979) Associate Dean for Faculty Development at Georgetown (2013–2021) Her research integrates bioinformatics and gene-regulatory mechanisms to analyze estrogen signaling pathways in breast cancer risk across diverse gender expressions. She pioneered investigations into circular RNA (circRNA) roles as biomarkers and explores their modification through anti-hormonal therapies. Current article trends show interdisciplinary work bridging quantum computing with network medicine , while maintaining focus on hormonal cancer mechanisms and vaccine immunology . Her 2024 publications emphasize multi-omics data integration and gender-inclusive oncology . Scientific recognition includes: 2023 Anna Boyksen Fellowship 2021 Women in Pathology Spotlight 2020 Excellence in Mentorship Award 2010 Georgetown Women in Medicine Award As Associate Dean, she developed faculty growth programs and continues mentoring through her TUM-IAS fellowship collaborations.

Wenrui Liمشاهده پروفایل

استادیار

• Statistics for network data
• Causal inference
• High-dimensional data analysis
• +۳ مورد دیگر

Wenrui Li serves as an Assistant Professor in the Department of Statistics at the University of Connecticut, where she develops advanced statistical methodologies for complex biomedical data structures. Her work bridges theoretical statistics and practical healthcare applications, with particular emphasis on network-based modeling and high-dimensional data analysis in oncology and epidemiology. Dr. Li's research program centers on statistics for network data, causal inference under interference, and Bayesian modeling of structured high-dimensional datasets. She pioneers techniques for handling network noise in graph-guided models, with direct applications to cancer genomics, multi-omics integration, and infectious disease surveillance. Her methodological innovations address critical challenges in noisy data environments where traditional statistical approaches fail. Analysis of her 2021-2025 publications reveals three dominant research threads: (1) Digital health interventions to reduce time burden in cancer care, exemplified by her TIME text-messaging system; (2) Graph-guided Bayesian methods for multi-omics data integration with noisy network priors; and (3) Epidemiological modeling of time-varying parameters in noisy surveillance systems. These threads demonstrate consistent focus on methodological rigor applied to pressing biomedical problems. No scientific awards, student advisement records, grant funding details, or laboratory affiliations were documented in the source materials. Her collaborative work spans biostatistics, oncology, and network science, with frequent co-authorship on interdisciplinary projects addressing cancer care optimization and disease modeling.

Murat Acarمشاهده پروفایل

استاد

• Systems Biology
• Computational Biology
• Synthetic Biology
• +۹ مورد دیگر

Murat Acar is a Professor in the Department of Medical Biology at the School of Basic Medical Sciences, Koç University. Previously, he served as a full-time faculty member at Yale University's Department of Molecular Cellular & Developmental Biology and Yale Systems Biology Institute from 2012 to 2022, where he was promoted to Associate Professor in 2017. Education: PhD in Physics, Massachusetts Institute of Technology (2007) Bachelor's in Physics, Boğaziçi University (2000) His research program focuses on Systems Biology , Computational Biology , and Synthetic Biology approaches to uncover genetic, epigenetic, and pharmaceutical modulators of cellular aging and organismal lifespan. The ACAR Lab integrates experimental systems biology with machine/deep learning methods, utilizing microfluidic technologies and single-cell RNA sequencing to investigate noise in gene expression, synthetic circuit design, and drug screening for aging-related pathways. Major Scientific Awards: NIH Director's New Innovator Award (2014) Ellison Medical Foundation New Scholar in Aging Award (2013) Yale Junior Faculty Fellowship (2014-2015) CBCD Fellow at Caltech (2007-2011) Professor Acar leads the ACAR Lab, which develops computational frameworks and experimental platforms to study cellular aging mechanisms through feedback regulation in gene networks and synthetic circuit implementations. His work bridges fundamental biological principles with translational applications for lifespan modulation.

Achuth Padmanabhanمشاهده پروفایل

استادیار

• Cancer Biology
• Molecular Oncology
• Ovarian Cancer
• +۷ مورد دیگر

Achuth Padmanabhan is an Assistant Professor in the Department of Biological Sciences at the University of Maryland, Baltimore County (UMBC), where he conducts cutting-edge research on ovarian cancer pathogenesis and therapeutic resistance. He is affiliated with the Interdisciplinary Life Sciences Building and leads an active research laboratory focused on molecular oncology and translational cancer research. Education: BS, Bharathidasan University (2005) PhD, University of Maryland Baltimore County (2011) Postdoctoral Training, Yale University (2015) Instructor, Baylor College of Medicine (2019) Dr. Padmanabhan's research centers on understanding how normal cells transform into cancerous ones, particularly focusing on ovarian cancer. His lab investigates tumor microenvironment dynamics, mechanisms of metastasis, and the molecular basis of chemoresistance. Using multidisciplinary approaches—including molecular, cellular, and organismic tools—his team explores key signaling pathways, protein degradation systems, and transcriptional regulators involved in cancer progression. Specific interests include p53 mutants, ZNF217, ADCK5 kinase, and proteasome isoforms. The recent publications and grants reflect a strong trend toward translational and clinically relevant research, with increasing emphasis on identifying novel therapeutic combinations, overcoming drug resistance, and developing clinically actionable strategies for metastatic ovarian cancer. His work bridges basic science with therapeutic innovation. Scientific Awards and Grants: Scientific Scholar Award – Rivkin Center for Ovarian Cancer American Cancer Society Institutional Research Grant Multiple ATIP Grants – UMB ICTR Elsa U. Pardee Foundation Grant Technology Catalyst Fund Award – UMBC UMBC Summer Research Faculty Fellowship (SURFF) Department of Defense Grants (multiple) National Institutes of Health Grant Ovarian Cancer Alliance of Greater Cincinnati Grants Entrepreneurship and Innovation Grants at UMBC Dr. Padmanabhan has secured substantial grant funding as Principal Investigator from federal, foundation, and institutional sources, demonstrating strong research leadership and external validation. His grants support both basic discovery and translational initiatives, including technology commercialization and curriculum innovation. He mentors graduate students and postdoctoral researchers through his lab and collaborative projects, though specific advisee names are not listed publicly. He is actively involved in academic entrepreneurship and innovation, having received funding from the Alex. Brown Center for Entrepreneurship and supporting curriculum development in innovation. His lab operates within UMBC’s Interdisciplinary Life Sciences Building, leveraging institutional partnerships with UMB and the University of Maryland Cancer Center to advance collaborative, high-impact cancer research.

J. Mark Shrimptonمشاهده پروفایل

استاد

• Environmental Physiology
• Molecular Ecology
• Population Structure
• +۴ مورد دیگر

J. Mark Shrimpton is a Professor at the University of Northern British Columbia in the Ecosystem Science and Management (Biology) Program . He focuses on the physiological and ecological responses of fish to environmental changes, particularly salmonids. His research integrates environmental physiology , molecular ecology , and population structure to address how anthropogenic disturbances affect fish behavior, survival, and genomic architecture. Recent studies emphasize temperature, flow, and salinity impacts on smolt development and spawning migrations. Key themes in his publications include hormonal regulation in osmoregulation, life history strategies, and conservation of migratory fish populations. Collaborative work spans institutions like the University of Windsor and Thompson Rivers University. Education: PhD in Zoology, University of British Columbia (1993) MSc in Zoology, University of British Columbia (1987) BSc (Honours) in Biology, University of Victoria (1985) Students: Sarah Ballard (2011), Arctic grayling distribution Marley Bassett (2012), sockeye salmon life history Melinda Bahr (2002), bull trout life history Adrian Clarke (2004), fish otolith analysis Rachel Johnson (2003), Chinook salmon induction efficiency Cathy Mackay (2006), logging impacts on aquatic ecosystems Crystal McRae (2009), coho salmon spawning sites Kyla Warren (2010), coho salmon movement Cory Williamson (2006), bull trout habitat use

Chris Smithمشاهده پروفایل

استاد

• Alternative pre-mRNA splicing
• Vascular smooth muscle cells
• RNA-binding proteins
• +۳ مورد دیگر

Chris Smith is a Professor in the Department of Biochemistry at the University of Cambridge, leading research on the mechanisms of regulated alternative pre-mRNA splicing. His work combines molecular, biochemical, and computational approaches to study splicing regulators in vascular smooth muscle cells and lymphoid systems. Key research focuses include the master regulator RBPMS, phosphorylation-driven splicing activity, and PTBP1's role in B cell selection. Research Interests: Mechanisms of alternative splicing regulation RBPMS's role in smooth muscle cell differentiation PTBP proteins in immune cell function Global splicing networks and regulatory interactions Collaborations include Sanjay Sinha (Cambridge Stem Cell Institute), Helle Jørgensen (Department of Medicine), and Martin Turner (Babraham Institute). The group investigates splicing's role in cell-specific phenotypes and disease relevance. Lab activities include transcriptomic, proteomic, and structural studies. Contact: cwjs1@cam.ac.uk

Julia Schulze-Hentrichمشاهده پروفایل

استاد

• Epigenetics
• Gene Expression
• Neurodegenerative Diseases
• +۱۲ مورد دیگر

Prof. Dr. Julia Schulze-Hentrich is a full Professor of Genetics at Saarland University, within the Faculty of Natural Sciences and Technology and the Department of Biosciences. She leads an active research group focused on epigenetic and transcriptomic mechanisms in health and disease, with a strong emphasis on neurodegenerative disorders, ageing, and sex-specific differences. She is also an INM Fellow at the Leibniz Institute for New Materials starting 2025, enhancing interdisciplinary collaboration in biomaterials and epigenetics. Her research interests include: Epigenetic modifications in neurodegenerative diseases (Parkinson’s and Huntington’s) Role of gene-environment interactions in disease pathogenesis Ageing-related epigenetic and transcriptomic changes Sex-dimorphic gene regulation in brain disorders Development of epigenetic signatures for diagnosing rare diseases Integration of multi-omics data and computational epigenomics Prof. Schulze-Hentrich leads the DFG Priority Program SPP2561 "SEXandGLIA", is part of the Center for Gender-specific Biology and Medicine (CGBM), and leads the epigenomics workgroup in the international solveRD consortium. Her lab operates the Epigenomics Sequencing Facility (ESF), equipped with advanced NGS platforms and bioinformatics pipelines. She co-developed widely used tools such as RnBeads, BiQ Analyzer HiMod, and MeDeCom. She is actively involved in academic training, co-organizing the GENIE Summer School on sex differences in glia-neuron interactions. She supervises students and researchers, offering B.Sc. and M.Sc. projects, and welcomes graduate and postdoctoral candidates. Scientific collaborations include the Max Planck Institute for Informatics, University Hospital Regensburg, Ruhr University Bochum, and the INM. Her team includes several scientific and technical staff, reflecting a vibrant, interdisciplinary research environment.

Chloe E. Atreyaمشاهده پروفایل

استاد

• Gastrointestinal Cancer
• Colorectal Cancer
• Tumor Genetics
• +۵ مورد دیگر

Dr. Chloe E. Atreya is a Professor of Medical Oncology at the University of California San Francisco (UCSF) School of Medicine, specializing in gastrointestinal and colorectal cancers at the UCSF Helen Diller Comprehensive Cancer Center. She co-directs the Integrative Oncology Program and Research Hub, focusing on tumor genetics, personalized therapy, and gut microbiome interactions to improve patient outcomes. Her research integrates clinical trials with molecular analysis to overcome treatment resistance. Dr. Atreya's educational background includes: BA in Molecular Biology with Visual Art Certificate from Princeton University (1998) PhD in Pharmacology and MD from Yale University (2004, 2005) Internal Medicine residency at University of Washington (2008) Medical Oncology fellowship and Advanced Clinical Research Training at UCSF (2010, 2014) Clinical Fellowship in Integrative Medicine (2018-2019) Her research spans tumor genetics, gut microbiome interactions, and integrative oncology approaches. Recent publications reveal strong focus on microbiome-mediated drug metabolism, precision medicine strategies for KRAS/BRAF-mutant cancers, and patient-centered interventions for cancer survivors. She leads multiple NIH-funded projects examining resistance mechanisms and nutritional interventions. Dr. Atreya has received significant recognition including: ASCO Young Investigator Award (2011) Multiple UCSF research awards (2012-2017) Sandler Program Breakthrough Award (2022) ASCO-Integrative Oncology Clinical Guidelines leadership As Principal Investigator on multiple NIH grants including R01CA229447 and R37CA266549, she directs translational research programs examining kinome-guided targeting and KRAS inhibition resistance. Her work bridges basic science with clinical applications through the Integrative Oncology Research Hub, developing evidence-based complementary approaches for symptom management and quality of life improvement.

Jacquin C. Nilesمشاهده پروفایل

دانشیار

• Malaria
• Infectious Disease
• Plasmodium falciparum
• +۷ مورد دیگر

Jacquin C. Niles is the Whitaker Professor in Biomedical Engineering at the Massachusetts Institute of Technology, where he holds a joint appointment in the Department of Biological Engineering. He serves as Director of the MIT Center for Environmental Health Sciences and is an Associate Member of the Broad Institute. As an HHMI-Gates Faculty Scholar, Dr. Niles leads a research program focused on developing molecular tools to combat infectious diseases, particularly malaria. Education: B.S. in Chemistry, Massachusetts Institute of Technology M.D., Harvard Medical School Ph.D. in Molecular Toxicology, Massachusetts Institute of Technology Postdoctoral training, Department of Chemistry, UC Berkeley (Michael Marletta's lab) Dr. Niles' research program centers on developing innovative molecular tools to address critical questions in infectious disease biology, with a specific focus on malaria and Plasmodium falciparum . His lab emphasizes creating a versatile molecular toolkit for controlling gene expression and protein function in malaria parasites, which enables the elucidation of parasite gene function. This work integrates expertise across biomolecular engineering, chemical biology, synthetic biology, analytical chemistry, biochemistry, and molecular and cell biology to develop solutions applicable across various pathogens and model organisms. Analysis of Dr. Niles' recent publications reveals a consistent focus on developing and applying novel molecular technologies to malaria research. His work spans CRISPR-based genome editing, RNA-protein interaction systems for gene regulation, biosensor development for heme and zinc metabolism, and microfluidic approaches for malaria diagnostics. These publications demonstrate a progression from fundamental tool development to increasingly sophisticated applications in parasite biology and host-pathogen interactions. Scientific Awards: HHMI-Gates Faculty Scholar Dr. Niles has mentored numerous graduate students, postdoctoral researchers, and undergraduates through the Niles Laboratory. His former students have gone on to successful careers in academia, industry, and medicine. His research program has been supported by various grants that enable the development of novel molecular approaches to studying and combating malaria. The lab consists of a multidisciplinary team of Biological Engineers, Chemists, and Microbiologists working collaboratively to address challenges in infectious disease research. The Niles Laboratory, located at MIT, serves as a hub for innovative research at the intersection of engineering and infectious disease biology. The lab's collaborative environment fosters the development of new technologies that have applications beyond malaria research, contributing to broader advances in molecular biology and biomedical engineering.

Sara Ekمشاهده پروفایل

استاد

• Lymphoma
• B Cell Lymphomas
• Cancer and Oncology
• +۴ مورد دیگر

Sara Ek is a Professor and Deputy Head of Department at the Department of Immunotechnology within the Faculty of Engineering (LTH) at Lund University. She serves as Principal Investigator at the Lund University Cancer Centre (LUCC), Director of Create Health, and is a Researcher in the eSSENCE: The e-Science Collaboration. Her academic profile demonstrates a strong commitment to advancing cancer research, particularly in lymphoid malignancies. Dr. Ek's research program, "Cancer Target Group– molecular and functional analysis in lymphoid proliferative disorders," focuses on finding biological solutions to clinically important questions involving improved diagnosis, stratification, and treatment of lymphoma patients. Recognizing that cancer heterogeneity presents a major challenge to successful treatment, her team develops tools to capture this heterogeneity and identify variations in tumor-related signaling pathways and interactions with the immune microenvironment. This work involves close collaboration with clinicians to perform advanced molecular investigations using sequencing, spatial omics technologies, serum protein profiling, and functional screening of patient materials from clinical trials. Her publication record reveals a consistent trajectory of impactful research in lymphoma, particularly mantle cell lymphoma, with groundbreaking work on the SOX11 transcription factor as a diagnostic biomarker. More recently, her research has expanded into spatial analysis of tumor immune microenvironments across different cancer types, including ovarian cancer. This evolution demonstrates her ability to leverage emerging technologies to address complex questions in cancer biology. Active Projects: A cellular and molecular dissection of the lymphoma tumor immune microenvironment to understand and address treatment resistances (2025-2028) MULTIPLY: MULITlayer Predictive models for relapsed MCL after ibrutinib as first line therapy (2024-2027) Primary ibrutinib resistance in mantle cell lymphoma – translational immuno-oncology investigations (2024-2026) Dr. Ek manages the SpatialOmics@LU infrastructure facility and has organized multiple scientific events including the LUCC Immunology minisymposium on digital spatial profiling in February 2024, demonstrating her leadership in both research and academic community building.

• Metabolic Disease
• Epigenetics
• Cardiovascular Disease
• +۳ مورد دیگر

Brad Ferguson is an Associate Professor in the Department of Environmental Sciences & Health at the University of Nevada, Reno. His research investigates the epigenetic mechanisms linking metabolic diseases like obesity and diabetes to cardiac remodeling, with a focus on histone deacetylases (HDACs), acetyltransferases (HATs), and dietary bioactives. Key techniques: bioinformatics, cell culture, animal models. Primary research themes: chromatin regulation, metabolic-cardiovascular crosstalk, microbiome-epigenome interactions. The lab emphasizes dietary epigenetic modifiers and translational approaches to develop therapies for cardio-metabolic disorders. Recent publications highlight intersections between: Epigenetic aging and caloric restriction HDAC inhibition in cardiac/hypertension models Muscle physiology and post-translational modifications Nutritional programming in livestock and human systems No scientific awards were explicitly documented in the provided materials.

• Microbiology
• Immunology
• Bacterial Pathogenesis
• +۷ مورد دیگر

Paul Brett is a Professor in the Department of Microbiology and Immunology at the University of Nevada, Reno School of Medicine. With over 25 years of experience researching Burkholderia pseudomallei , the causative agent of melioidosis, Dr. Brett leads a laboratory focused on understanding molecular mechanisms of bacterial pathogenesis and developing effective vaccines against this significant infectious disease. Dr. Brett received his B.Sc. in Biochemistry from the University of Victoria and his Ph.D. in Bacterial Pathogenesis from the University of Calgary. His academic credentials have supported a distinguished career investigating bacterial virulence mechanisms, particularly focusing on how B. pseudomallei evades host immune defenses through specialized surface structures. Dr. Brett's research program centers on elucidating how lipopolysaccharides and capsular polysaccharides expressed by B. pseudomallei contribute to immune evasion. His laboratory has developed significant expertise in carbohydrate purification/characterization, glycoconjugate synthesis, and comprehensive analysis of humoral/cellular immune responses. The ultimate goal of his research is to identify correlates of antigen-induced immunity against B. pseudomallei to develop safe, affordable, and effective melioidosis vaccines that could address this serious public health threat. Analysis of Dr. Brett's publication history reveals a consistent research trajectory with publications spanning from the early 2000s through 2025. His work demonstrates increasing sophistication in vaccine development approaches, with recent publications focusing on glycoconjugate vaccines, structural analysis of bacterial components, and innovative diagnostic methods for melioidosis. His research bridges molecular microbiology and translational immunology, with direct applications to vaccine design and development. Dr. Brett has participated in significant collaborative efforts, including the Melioidosis Diagnostic Workshop in 2013 and the Steering Group on Melioidosis Vaccine Development. These collaborations highlight his standing as a recognized expert in the field and his commitment to advancing international efforts to combat melioidosis. Though specific details about current students and grants are not provided in the available materials, Dr. Brett's active publication record through 2025 and his laboratory's described capabilities suggest he maintains a vibrant research program with ongoing funding and mentorship of graduate students and postdoctoral researchers. His work has direct relevance to both public health initiatives in melioidosis-endemic regions and biodefense preparedness efforts given B. pseudomallei 's classification as a Tier 1 select agent.

Ian Doddمشاهده پروفایل

استاد

• Plant Physiology
• Drought Stress
• Crop Water Use Efficiency
• +۶ مورد دیگر

Professor Ian Dodd is a Professor of Sustainable Agriculture at Lancaster University's Lancaster Environment Centre, specializing in plant responses to drought stress and irrigation management. He serves as Director of Study for the Food Security (Distance Learning) MSc program and has published over 100 refereed journal papers focusing on improving crop water use efficiency. Lancaster Environment Centre, Lancaster University Professor of Sustainable Agriculture Director of Study for Food Security MSc Handling editor for Journal of Experimental Botany and Plant and Soil His research investigates fundamental mechanisms by which plant root systems communicate drought effects to shoots, aiming to improve 'crop per drop' in changing climates. He studies irrigation techniques including 'partial rootzone drying' and 'alternate wetting and drying,' soil amendments, and root physiology. His work has practical applications in the UK and internationally through projects funded by the Global Challenges Research Fund and European Union. Analysis of his recent publications (2023-2025) reveals a strong focus on plant hormone signaling under drought conditions, particularly abscisic acid (ABA) transport and interactions with other hormones. His research spans multiple crops including soybean, tomato, potato, and grapevines, with emphasis on root-shoot communication, irrigation management, and practical solutions for water conservation in agriculture. Professor Dodd supervises 6 postgraduate research students working on topics including root physiology, rootzone CO 2 enrichment, and soil amendments. His laboratory regularly receives international visitors from countries including Spain, Italy, Turkey, and China. He has secured significant research funding from diverse sources including the Global Challenges Research Fund (RECIRCULATE), European Union (SHUI, DROPS, ROOTOPOWER, SIRRIMED, WATBIO), Agriculture & Horticulture Development Board, Biotechnology and Biological Sciences Research Council, British Council Newton Fund, and Royal Society. His laboratory investigates root physiology and phenotyping, with current projects examining rootzone CO 2 enrichment and various soil amendments including alternative liming agents, plant growth promoting rhizobacteria, and surfactants. He collaborates extensively with international researchers on agricultural water management projects.

Eve Romanمشاهده پروفایل

استاد

• Cancer Epidemiology
• Haematological Malignancies
• Childhood Cancer
• +۳ مورد دیگر

Eve Roman is a Professor in Epidemiology and Cancer Statistics at the University of York's Department of Health Sciences. She co-founded the Haematological Malignancy Research Network (HMRN) in 2004, which utilizes NHS infrastructure to track 38,000 blood cancer patients for clinical and research purposes. Her work focuses on cancer epidemiology with a specific interest in haematological malignancies and childhood cancer using population-based data. Education : BSc in Applied Biology, Brunel University PhD in Epidemiology, London School of Hygiene & Tropical Medicine Her research explores epidemiological study design and routinely collected health data to analyze risk factors like maternal health and adverse reproductive outcomes. She has contributed to major projects such as the UK Childhood Cancer Study (UKCCS) and European Myelodysplastic Syndromes Registry (EUMDS) , emphasizing real-world data for informed clinical decisions. Recent publications highlight her work on chronic blood cancer patient experiences (2024), maternal pregnancy exposures and childhood cancer (2024), and genetic subtypes in lymphoma (2022). These studies demonstrate her expertise in qualitative research methods and genetic epidemiology . Scientific awards include: Editor-in-Chief of Cancer Epidemiology (Elsevier) Honorary Visiting Professor at the London School of Hygiene and Tropical Medicine Member of the Childhood Leukaemia International Consortium (CLIC) Contributor to the International Lymphoma Epidemiology Consortium (InterLymph) She supervises PhD and Master’s students in haematological malignancy epidemiology and teaches undergraduate modules like Understanding Health and Disease . Her external roles involve advisory positions on the Yorkshire and Humber Haematology Cancer Network and the UKCCS Research Committee .